Juhász Csaba, Bosnyák Edit
Departments of Pediatrics, Wayne State University, Detroit, MI, USA.
Departments of Neurology, Wayne State University, Detroit, MI, USA.
Childs Nerv Syst. 2016 Oct;32(10):1823-32. doi: 10.1007/s00381-016-3125-z. Epub 2016 Sep 20.
Molecular imaging is playing an increasing role in the pretreatment evaluation of low-grade gliomas. While glucose positron emission tomography (PET) can be helpful to differentiate low-grade from high-grade tumors, PET imaging with amino acid radiotracers has several advantages, such as better differentiation between tumors and non-tumorous lesions, optimized biopsy targeting, and improved detection of tumor recurrence. This review provides a brief overview of single-photon emission computed tomography (SPECT) studies followed by a more detailed review of the clinical applications of glucose and amino acid PET imaging in low-grade hemispheric gliomas. We discuss key differences in the performance of the most commonly utilized PET radiotracers and highlight the advantage of PET/MRI fusion to obtain optimal information about tumor extent, heterogeneity, and metabolism. Recent data also suggest that simultaneous acquisition of PET/MR images and the combination of advanced MRI techniques with quantitative PET can further improve the pretreatment and post-treatment evaluation of pediatric brain tumors.
分子成像在低级别胶质瘤的治疗前评估中发挥着越来越重要的作用。虽然葡萄糖正电子发射断层扫描(PET)有助于区分低级别和高级别肿瘤,但使用氨基酸放射性示踪剂的PET成像具有多个优势,例如肿瘤与非肿瘤性病变之间的区分更好、活检靶向优化以及肿瘤复发检测的改善。本综述简要概述了单光子发射计算机断层扫描(SPECT)研究,随后更详细地回顾了葡萄糖和氨基酸PET成像在低级别半球胶质瘤中的临床应用。我们讨论了最常用的PET放射性示踪剂在性能上的关键差异,并强调了PET/MRI融合在获取有关肿瘤范围、异质性和代谢的最佳信息方面的优势。最新数据还表明,同时采集PET/MR图像以及将先进的MRI技术与定量PET相结合可以进一步改善儿童脑肿瘤的治疗前和治疗后评估。